Our goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies. Based on our well-proven FMA technology, we increase the value and extend the market life of a prescription product for our partners. Our services are designed specifically to help support the clinical path our pharmaceutical partners have chosen for their product development. We offer a full spectrum of capabilities starting from the earliest stage of feasibility study through large-scale commercial operation using our regulatory approved FMA product. Our capabilities include:      In vitro drug permeation studies in diffusion cells using       human skin (surgical waste, cadaver or other animal skins.

     Design and testing of pharmaceutical topical, intraepidermal and transdermal formulations.

     Conducting in vivo studies with mice, rabbits, hairless rats, hairless guinea pigs for drug
      pharmacokinetics following topical/intraepidermal application.

     Conducting in vivo studies for drug pharmacokinetics following intraepidermal drug delivery.

     Conducting in vivo toxicity and dermal tolerance studies in all animal models, including skin
      irritation and sensitization protocols.

     Conducting human clinical trials outside US to lower cost and shorten development time.